U.S. law firm Goodwin Procter has hired private equity specialist Daniel Dusek as partner in Hong Kong from Kirkland & Ellis.

Dusek is Goodwin’s most recent addition to the PE practice in the past year. In June last year, Edwin Chan joined Goodwin’s Hong Kong office as a partner from Paul, Weiss, Rifkind, Wharton & Garrison. Then in October, it hired Phil Culhane and Elyn Xing as partners from Culhane & Associates and Debevoise & Plimpton, respectively.

With more than 20 years of experience in cross-border corporate issues including M&A, disposals, auctions, private equity and leveraged buyouts, take-privates, spin-offs and joint ventures, Dusek advises large private equity investors and corporations.

Dusek joined Kirkland in 2017. Prior to that, he spent 17 years at Skadden, Arps, Slate, Meagher & Flom in New York, Beijing and Hong Kong.

With this addition, Goodwin now has 13 partners in Hong Kong.


Related Articles

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

HK: Goodwin adds debt finance expert from White & Case

by Nimitt Dixit |

U.S. law firm Goodwin Procter has made its first Hong Kong partner hire in 2023 with the addition of debt finance attorney Stephen Howard from White & Case, where he was a local partner.

Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition

by Nimitt Dixit |

U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.